408 results on '"Kang, Chunsheng"'
Search Results
2. EPIC-0628 abrogates HOTAIR/EZH2 interaction and enhances the temozolomide efficacy via promoting ATF3 expression and inhibiting DNA damage repair in glioblastoma
3. Compound AC1Q3QWB upregulates CDKN1A and SOX17 by interrupting the HOTAIR—EZH2 interaction and enhances the efficacy of tazemetostat in endometrial cancer
4. Association between behavioural risks and Alzheimer's disease: Elucidated with an integrated analysis of gene expression patterns and molecular mechanisms
5. AC1Q3QWB inhibits colorectal cancer progression by modulating the immune response and balancing the structure of the intestinal microbiota
6. Glioma-derived exosomes hijack the blood–brain barrier to facilitate nanocapsule delivery via LCN2
7. MET fusions and splicing variants convergently define a subgroup of glioma sensitive to MET inhibitors
8. CACA guidelines for holistic integrative management of glioma
9. HIF1α/ATF3 partake in PGK1 K191/K192 succinylation by modulating P4HA1/succinate signaling in glioblastoma.
10. Systemic delivery of microRNA for treatment of brain ischemia
11. Virus-like nanoparticle as a co-delivery system to enhance efficacy of CRISPR/Cas9-based cancer immunotherapy
12. The effect of umbrella-type branching on the blood circulation and tumor targeting of star-branched PLA-PMPC copolymer micelles
13. Elevated signature of a gene module coexpressed with CDC20 marks genomic instability in glioma
14. Deep‐targeted gene sequencing reveals ARID1A mutation as an important driver of glioblastoma.
15. Loss of ATRX suppresses ATM dependent DNA damage repair by modulating H3K9me3 to enhance temozolomide sensitivity in glioma
16. High-throughput sequencing of the immune repertoire in oncology: Applications for clinical diagnosis, monitoring, and immunotherapies
17. EGFR/c-myc axis regulates TGFβ/Hippo/Notch pathway via epigenetic silencing miR-524 in gliomas
18. EGFR-vIII downregulated H2AZK4/7AC though the PI3K/AKT-HDAC2 axis to regulate cell cycle progression
19. RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner
20. EPIC-1042 as a potent PTRF/Cavin1–caveolin-1 interaction inhibitor to induce PARP1 autophagic degradation and suppress temozolomide efflux for glioblastoma.
21. Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma.
22. EPIC-0307-mediated selective disruption of PRADX–EZH2 interaction and enhancement of temozolomide sensitivity to glioblastoma via inhibiting DNA repair and MGMT.
23. CGCG clinical practice guidelines for the management of adult diffuse gliomas
24. A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma
25. Lnc-TALC promotes O6-methylguanine-DNA methyltransferase expression via regulating the c-Met pathway by competitively binding with miR-20b-3p
26. DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression
27. ICAT inhibits glioblastoma cell proliferation by suppressing Wnt/β-catenin activity
28. EZH2 is a negative prognostic factor and exhibits pro-oncogenic activity in glioblastoma
29. Star-branched amphiphilic PLA-b-PDMAEMA copolymers for co-delivery of miR-21 inhibitor and doxorubicin to treat glioma
30. A novel compound EPIC-0412 reverses temozolomide resistance via inhibiting DNA repair/MGMT in glioblastoma.
31. PRMT2 links histone H3R8 asymmetric dimethylation to oncogenic activation and tumorigenesis of glioblastoma
32. Engineering chimeric antigen receptor-T cells for cancer treatment
33. miR-146b-5p inhibits glioma migration and invasion by targeting MMP16
34. PRDM1 is directly targeted by miR-30a-5p and modulates the Wnt/β-catenin pathway in a Dkk1-dependent manner during glioma growth
35. MiR-24 regulates the proliferation and invasion of glioma by ST7L via β-catenin/Tcf-4 signaling
36. Retraction Notice to: Precise editing of FGFR3-TACC3 fusion genes with CRISPR-Cas13a in glioblastoma
37. miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2
38. MicroRNA-221 and -222 Regulate Radiation Sensitivity by Targeting the PTEN Pathway
39. RETRACTED: Precise editing of FGFR3-TACC3 fusion genes with CRISPR-Cas13a in glioblastoma
40. Editorial: The State-of-Art in Immuno-Oncology, What to Do With Glioblastoma?
41. Blood exosomes-based targeted delivery of cPLA2 siRNA and metformin to modulate glioblastoma energy metabolism for tailoring personalized therapy.
42. Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status
43. Effects of diesel exhaust particles on microRNA-21 in human bronchial epithelial cells and potential carcinogenic mechanisms
44. miR-19a and miR-19b Overexpression in Gliomas
45. Antisense MMP-9 RNA inhibits malignant glioma cell growth in vitro and in vivo
46. Wnt/beta-Catenin Signaling in Glioma
47. Nuclear Translocation of β-catenin is Essential for Glioma Cell Survival
48. MicroRNAs involved in the EGFR/PTEN/AKT pathway in gliomas
49. Suppression of matrix metalloproteinase-9 expression by RNA interference inhibits SGC7901 gastric adenocarcinoma cell growth and invasion in vitro and in vivo
50. The oncogenic roles of Notch1 in astrocytic gliomas in vitro and in vivo
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.